Guide
Grey-market vials: what can go wrong
Semaglutide and tirzepatide sold as freeze-dried powder in vials have none of the protections of a licensed pen. You can't tell a good vial from a bad one by looking at it. This guide also covers reactions where you inject, and what can cause them.
Why vials are harder to check than pens
A licensed pen comes from one known manufacturer, with batch records, a tamper seal and, in the EU, a barcode checked by the pharmacy. A vial labelled "research use only" has none of that. The label can be printed by anyone, and the white powder inside looks the same whether it contains the right drug, a different drug, or nothing.
What can be wrong with a vial
| Problem | What it means | Can you see it? |
|---|---|---|
| Wrong molecule | A different peptide than the label says. The FDA has found compounded products containing retatrutide and cagrilintide marketed as semaglutide or tirzepatide alternatives. | No |
| No active drug | Filler only. You inject and nothing happens, or you raise the amount and the next batch is real. | No |
| Wrong amount | More or less than the labelled milligrams. Either way, every measured dose is off. | No |
| Low purity | Breakdown products or synthesis by-products mixed with the drug. | No |
| Contamination | Bacteria or bacterial toxins (endotoxin). Filtering the mixed solution removes bacteria but not endotoxin. | No |
Itching, redness, swelling or heat where you injected
Some reaction at the injection site is common even with licensed medicines. In Lilly's trials of licensed tirzepatide, injection-site reactions were reported by 3.2% of people on the drug against 0.4% on placebo in diabetes studies, and by 2.1% to 11.1% in the weight-loss studies. They covered redness, pain, itching, swelling and hardening of the skin, and none was severe or serious. So a mild, short-lived reaction doesn't mean a vial is fake. Some signs, though, point to something more than the drug itself.
| What you notice | Usually | What to do |
|---|---|---|
| Mild redness, itching or a small bump that fades within a day or two | Common Also seen with licensed products | Keep an eye on it. Use a different spot next time. |
| Bruising or brief stinging when injecting | Common Often the needle or the solution itself | Keep an eye on it. |
| The same strong reaction after every dose, at every site | Check Possible allergy, or something irritating in the vial | Stop and talk to a doctor or pharmacist before the next dose. |
| Hives or itching beyond the injection site, swelling of the face, lips or throat, trouble breathing | Emergency Possible serious allergic reaction | Get emergency help now. |
| The spot gets hot, redness spreads, pain increases, a lump grows or leaks pus | Urgent Signs of infection | See a doctor the same day. Infections can spread under the skin. |
| Fever, chills, shaking, a racing heart or feeling flu-like within hours of a dose | Urgent Possible endotoxin or bacteria in the solution | Get medical help now. Don't inject from that vial again. |
This table is a guide, not a diagnosis. If you're unsure, or a reaction is getting worse, get medical advice. Tell the doctor exactly what you injected and where it came from, and bring the vial.
What can cause a bad reaction with a grey-market vial
| Possible cause | What happens | Typical signs |
|---|---|---|
| Bacteria in the vial or the mixed solution | The powder wasn't made or filled under sterile conditions, or bacteria got in while mixing or drawing doses. Multi-dose vials carry more risk the longer they're in use; the FDA recommends using even pharmacy multi-dose vials within 28 days of first use. | Heat, spreading redness, growing pain, swelling, pus, fever |
| Endotoxin | A toxin from the cell walls of bacteria. It stays in the solution after the bacteria are killed or filtered out, so a "sterile" vial can still contain it. In a 2026 US recall of a compounded peptide injection with high endotoxin, the FDA received reports of nausea, vomiting, a racing heart and injection-site reactions, and warned that high endotoxin in injectables is linked to anaphylactic shock and death. | Fever, chills, flu-like feeling, racing heart, often within hours |
| Impurities or the wrong molecule | Breakdown products, synthesis by-products, clumped peptide or a different substance altogether. The body can react to these as foreign. | Itching, hives, strong local reactions after every dose |
| Too much drug | The vial holds more than the label says, so every measured dose is too high. One study of vials bought online without a prescription found all three contained more semaglutide than labelled. | Mostly the drug's own side effects: nausea, vomiting, stomach pain, rather than skin signs |
| Chemical leftovers or a harsh solution | Traces of chemicals from peptide synthesis, such as trifluoroacetic acid (TFA), or a solution that is too acidic. | Stinging or burning while injecting, local irritation |
| Damage in shipping or storage | Peptides break down when kept warm. The FDA advises not using an injectable GLP-1 that arrives warm or without enough cooling. | The drug works less well; breakdown products can add to reactions |
| How it was prepared and injected | Reused needles, unclean skin, non-sterile liquid used for mixing, or injecting in the same spot every time. This can cause problems even with a good vial. | Infection or irritation at the site |
A reaction on its own can't tell you which of these caused it, or whether the vial is genuine. Only lab tests can: sterility and endotoxin tests for contamination, LC-MS for identity, HPLC for purity and amount. See understanding lab results.
If you've had a reaction
Stop using the vial, keep it and its packaging, and see what to do next, including how to report it to your medicines regulator. Reports of reactions are how regulators find bad batches.
Red flags
None of these proves a vial is fake, and a seller with none of them can still sell a bad batch. They are reasons to be more careful.
- "Research use only" on the label, while the seller or its affiliates talk about weight loss. The FDA has cited exactly this in warning letters.
- A price far below what other sellers charge for the same amount.
- A certificate of analysis you can't verify with the lab, or the same certificate reused across batches.
- No batch number on the vial, or a batch number that doesn't match the paperwork.
- Sold through social media messages, discount codes from influencers, or group chats.
The only way to know what's inside
Identity, amount and purity can only be measured with analytical methods. See your testing options and what they cost.
- JumpstartMD: FDA findings on compounded products containing retatrutide and cagrilintide
- Axios: FDA warning letters to "research use only" sellers, Aug 2026
- EMA: safety features for medicines sold in the EU
- Lilly Medical: injection-site reactions with Mounjaro (tirzepatide)
- Lilly Medical: injection-site reactions with Zepbound in the SURMOUNT studies
- FDA: concerns with unapproved GLP-1 drugs used for weight loss (multi-dose vials, warm deliveries)
- Partnership for Safe Medicines: compounded peptide injections recalled for high endotoxin, Aug 2026
- Ashraf et al., JAMA Network Open 2024: semaglutide bought online without a prescription